Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 428


 
 Table of Contents  
CASE REPORT
Year : 2016  |  Volume : 8  |  Issue : 2  |  Page : 117-120

Drug-induced pancreatitis: A rare manifestation of doxycycline administration


1 Department of Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College, New York City, New York, USA
2 Department of Medicine, Mount Sinai St. Luke's and Mount Sinai Roosevelt Hospitals, Icahn School of Medicine, New York City, New York, USA
3 Department of Radiology, Mount Sinai St. Luke's and Mount Sinai Roosevelt Hospitals, Icahn School of Medicine, New York City, New York, USA
4 Department of Medicine, Mayo Hospital, King Edward Medical University, Lahore, Pakistan

Date of Web Publication23-Feb-2016

Correspondence Address:
Faisal Inayat
Department of Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College, 525 East 68th Street, New York City - 10065, New York
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1947-2714.174348

Rights and Permissions
  Abstract 

Context: Drug-induced pancreatitis (DIP) is rare, but as there are no systematic data on it, the true incidence is not known. Although numerous and varied drugs have been associated with DIP, the clinical evidence on doxycycline-induced pancreatitis is sparse. Case Report: We present the case of a 58-year-old female who presented with complaints of nausea and severe epigastric pain. Her medications included doxycycline which she had been on for only 2 days. Computed tomography of her abdomen showed mild enlargement of body of the pancreas with peripancreatic fatty infiltration, along with lipase level suggestive of acute pancreatitis. In the absence of classical risk factors for acute pancreatitis, a diagnosis of DIP secondary to doxycycline therapy was made. Immediate withdrawal of the drug was accompanied by relief of symptoms and resolution of pancreatitis. Conclusion: This report implicates doxycycline as an etiological factor for acute pancreatitis. Knowledge regarding doxycycline related pancreatitis is of paramount importance in order to diagnose cases early and institute effective treatment in patients who are undergoing therapy with this drug.

Keywords: Acute pancreatitis, doxycycline, drug-induced pancreatitis (DIP)


How to cite this article:
Inayat F, Virk HU, Yoon DJ, Riaz I. Drug-induced pancreatitis: A rare manifestation of doxycycline administration. North Am J Med Sci 2016;8:117-20

How to cite this URL:
Inayat F, Virk HU, Yoon DJ, Riaz I. Drug-induced pancreatitis: A rare manifestation of doxycycline administration. North Am J Med Sci [serial online] 2016 [cited 2019 Nov 15];8:117-20. Available from: http://www.najms.org/text.asp?2016/8/2/117/174348


  Introduction Top


Acute pancreatitis is a life-threatening condition affecting around 45 per 100,000 people annually. [1] Drug-induced pancreatitis (DIP) is a rare variant of acute pancreatitis. The true incidence of DIP is not known and evidence has mainly been derived from case reports and case series. Doxycycline administration, albeit rare, may result in DIP. The literature is scant on the association of DIP with doxycycline. [2],[3],[4] We present this unusual case in which DIP symptoms were demonstrated following the second day of initiation of doxycycline treatment. In our patient, diagnosis of DIP was made by exclusion of all common etiologies of acute pancreatitis such as alcohol, gallstones, hypercalcemia, hypertriglyceridemia, infection, trauma, or medical procedures such as endoscopic retrograde cholangiopancreatography (ERCP). After confirmation, the patient was treated with discontinuation of doxycycline and in addition, conservative treatment was instituted. The patient had an uneventful recovery and has been symptom-free for over 1 month.


  Case Presentation Top


A 58-year-old African-American female presented to the Emergency Department (ED) of Mount Sinai St. Luke's and Roosevelt Hospital Center with mild nausea and severe epigastric pain. Her past medical history was significant for hypertension, noninsulin-dependent diabetes mellitus, and osteoporosis with recent ankle and tibial bone fracture, which was managed with orthopedic procedures (Ilizarov ankle arthrodesis and fixation of tibia). On orthopedic outpatient follow-up, she was found to have internal pin (orthopedic hardware) site infection. She was prescribed doxycycline (Monodox ® , Par Pharmaceuticals Inc., Spring Valley, New York, USA) 200 mg twice a day per oral, in anticipation of repeat irrigation of the infected site. On the second day of initiation of doxycycline, the patient started feeling nauseous with epigastric pain, and came to visit the ED. The pain was rated as severe, gnawing in nature, and was radiating to the back. She was nonalcoholic, non-smoker, and drug-free.

The patient was hemodynamically stable. Physical examination revealed epigastric and right upper quadrant tenderness with hypoactive bowel sounds. Rebound tenderness and abdominal wall rigidity were absent. Laboratory evaluation was remarkable for serum lipase 2,508 IU/L (normal, 23-300) and C-reactive protein 5.8 mg/dL (normal, 0-1). Urinalysis was negative for acute infection and urine human chorionic gonadotrophin was negative for pregnancy. Liver function tests and lipid panel were within normal limits.

Ultrasound of the right upper quadrant demonstrated mild proximal dilatation of common bile duct with smooth tapering of the duct distally, which were usual findings as our patient had undergone cholecystectomy. No common bile duct stone was seen [Figure 1]. Computed tomography scan demonstrated mild enlargement of the body of the pancreas [Figure 2]. Peripancreatic fatty infiltration was evident and surgical clips were noted in the gallbladder fossa [Figure 3]. Necrosis or peripancreatic fluid collection was absent. Four months earlier, the patient had a normal-appearing pancreas and peripancreatic fat [Figure 4]. After ruling out common etiologies of acute pancreatitis, drug-induced pancreatitis (DIP) was diagnosed. On review of the literature for all possible drugs responsible for DIP, we concluded that our patient had doxycycline-induced pancreatitis.
Figure 1: Right upper quadrant ultrasound demonstrating mild proximal dilatation of the common bile duct with smooth tapering of the duct distally. No common bile duct stone is present

Click here to view
Figure 2: Contrast-enhanced computed tomography at the level of pancreas. Arrow demonstrates mild enlargement of the body of the pancreas

Click here to view
Figure 3: Contrast-enhanced computed tomography at the level of pancreas. Arrow in yellow color demonstrates peripancreatic fatty infiltration. Black arrowhead showed surgical clips in the gallbladder fossa indicating the patient's status after cholecystectomy

Click here to view
Figure 4: Contrast-enhanced computed tomography at the level of the pancreas performed 4 months prior to the current presentation. Normal-appearing pancreas and peripancreatic fat were demonstrated

Click here to view


Subsequently, doxycycline was discontinued. The patient was initiated on intravenous (IV) hydration, antiemetics, and morphine. IV vancomycin was administered for internal pin site infection. On the third day of hospital admission, the pain and nausea improved. After symptomatic improvement, she underwent an uneventful orthopedic procedure for washout of the infection site, and was discharged from the hospital after providing supportive care. One month follow-up visit revealed complete recovery of the symptoms.


  Discussion Top


DIP has an estimated incidence of 0.1-5.3% in the human immunodeficiency virus (HIV) negative population. [5],[6] A retrospective study concluded in 1993 in Germany demonstrated that 22 out of 1,613 (1.4%) cases of acute pancreatitis were related to drugs. [7] A recent report of 170 cases of acute pancreatitis from the Czech Republic demonstrated that 5.3% cases were of DIP. [6] Another study attributed an incidence of DIP to be 4.8% of all acute pancreatitis cases. [8] However, the exact incidence of DIP is difficult to determine owing to the rare presentation, and blind labeling of pancreatitis as idiopathic. It warrants larger, case-controlled studies to determine the incidence and prevalence of DIP.

DIP poses a diagnostic challenge to clinicians, as it has no specific clinical characteristics distinguishing it from other forms of acute pancreatitis. Biliary disease (38%) and alcoholism (36%) are the most common etiologies of acute pancreatitis. [9] In our case, imaging studies ruled out biliary disease and the patient had no history of alcohol abuse, with normal serum triglyceride. Although she had trauma and had undergone a recent surgery, the timing of onset of the symptoms was more consistent with doxycycline-induced disease.

According to the World Health Organization (WHO), over 525 different drugs were implicated in the etiology of DIP between 1968 and 1993. [10] Afterward, addition of new drugs to the list has been made, including numerous antibiotic medications. Tetracycline has long been designated as a causative agent in acute pancreatitis. However, there are only four reports of DIP following doxycycline, either as a monotherapy or in combination therapy, shown in [Table 1]. [2],[3],[4] To our surprise, all four were female patients. However, reports of doxycycline as the sole etiology of DIP, as in our case, are extremely rare. DIP manifests variable time of onset. Previously, antibiotic-associated pancreatitis has been reported after 1 month to almost immediately after the administration of drugs. [11],[12],[13] We believe our case is unique in terms of doxycycline as the sole etiology of DIP and symptoms of DIP developed 2 days after doxycycline therapy, which is the shortest reported time for doxycycline-induced pancreatitis.
Table 1: Data of the doxycycline-induced pancreatitis patients

Click here to view


Doxycycline is a well-studied and the Food and Drug Administration (FDA) approved tetracycline derivative antibiotic. It has well-supported clinical benefits in multidisciplinary practices. Doxycycline has been effectively used to treat a wide variety of bacterial infections, acne vulgaris, and periodontitis. However, doxycycline-induced pancreatitis is a rare but devastating condition and prompts the need of an early diagnosis. The exact pathophysiology for this phenomenon remains a mystery and can only be hypothesized on. In one large study conducted in the Netherlands involving 55 cases of DIP between 1977 and 1998, doxycycline was proposed to have a probable causal relationship in the development of acute pancreatitis. [14] Due to rarity of the condition, we may attribute DIP in our patient as an idiosyncratic drug reaction to doxycycline. The incidence and prevalence of idiopathic pancreatitis has been rapidly growing. Therefore, it is imperative to consider and study doxycycline and other drugs as possible culprits of acute pancreatitis.

In conclusion, we report this rare complication of doxycycline manifested in the form of DIP. A high index of suspicion for DIP should be maintained. Physicians should consider checking serum amylase and lipase levels for patients presenting with gastrointestinal symptoms, even as early as after a few days of doxycycline administration. Furthermore, new epidemiological studies are warranted to investigate this unusual association.

Acknowledgements

We are indebted to Dr. Zia Ur Rahman and Dr. Aitzaz Bin Sultan Rai for their invaluable editorial assistance.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013;144:1252-61.  Back to cited text no. 1
    
2.
Ocal S, Selçuk H, Korkmaz M, Unal H, Yilmaz U. Acute pancreatitis following doxycycline and ornidazole coadministration. JOP 2010;11:614-6.  Back to cited text no. 2
    
3.
Achecar Justo L, Rivero Fernández M, Cobo Reinoso J, Ruiz Del Arbol Olmos L. Doxycycline induced-acute pancreatitis. Med Clin (Barc) 2010;134:705-6.  Back to cited text no. 3
    
4.
Wachira JK, Jensen CH, Rhone K. Doxycycline-induced pancreatitis: A rare finding. S D Med 2013;66:227-9.  Back to cited text no. 4
    
5.
Balani AR, Grendell JH. Drug-induced pancreatitis: Incidence, management and prevention. Drug Saf 2008;31:823-37.  Back to cited text no. 5
    
6.
Vinklerová I, Procházka M, Procházka V, Urbánek K. Incidence, severity, and etiology of drug-induced acute pancreatitis. Dig Dis Sci 2010;55:2977-81.  Back to cited text no. 6
    
7.
Lankisch PG, Dröge M, Gottesleben F. Drug induced acute pancreatitis: Incidence and severity. Gut 1995;37:565-7.  Back to cited text no. 7
    
8.
Spanier BW, Tuynman HA, van der Hulst RW, Dijkgraaf MG, Bruno MJ. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol 2011; 106:2183-8.  Back to cited text no. 8
    
9.
Spanier BW, Dijkgraaf MG, Bruno MJ. Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update. Best Pract Res Clin Gastroenterol 2008; 22:45-63.  Back to cited text no. 9
    
10.
Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther 2003;17:887-93.  Back to cited text no. 10
    
11.
Nigwekar SU, Casey KJ. Metronidazole-induced pancreatitis. A case report and review of literature. JOP 2004;5:516-9.  Back to cited text no. 11
    
12.
Schouwenberg BJ, Deinum J. Acute pancreatitis after a course of claritromycin. Neth J Med 2003;61:266-7.  Back to cited text no. 12
    
13.
Chow KM, Szeto CC, Leung CB, Li PK. Recurrent acute pancreatitis after isoniazid. Neth J Med 2004;62:172-4.  Back to cited text no. 13
    
14.
Eland IA, van Puijenbroek EP, Sturkenboom MJ, Wilson JH, Stricker BH. Drug-associated acute pancreatitis: Twenty-one years of spontaneous reporting in The Netherlands. Am J Gastroenterol 1999;94:2417-22.  Back to cited text no. 14
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1]


This article has been cited by
1 Acute pancreatitis induced by etoposide–lobaplatin combination chemotherapy used for the treatment of lung cancer
Cheng-Liang Cao,Peng-Yu Duan,Wang-Jun Zhang,Le Li,Feng-Zhi Qu,Bei Sun,Gang Wang
Medicine. 2017; 96(29): e7601
[Pubmed] | [DOI]
2 Minocycline-Associated Pancreatitis
Joseph Gabriel Gabriel,Sukhdeep Bhogal,Aaysha Kapila
American Journal of Therapeutics. 2017; : 1
[Pubmed] | [DOI]
3 Doxycycline
Reactions Weekly. 2016; 1594(1): 87
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Case Presentation
Discussion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed2602    
    Printed86    
    Emailed1    
    PDF Downloaded506    
    Comments [Add]    
    Cited by others 3    

Recommend this journal